Increased interleukin-32 expression in chronic hepatitis B virus-infected liver

Journal of Infection

Volumn 65, Issue 4, 2012, Pages 336-342

  Xu, Qihuan ^a   Pan, Xingfei ^a   Shu, Xin ^a   Cao, Hong ^a   Li, Xuejun ^a   Zhang, Ka ^a   Lu, Jianxi ^a   Zou, Yong ^a   Li, Xueling ^b   Liu, Hongcan ^a   Zhang, Yeqiong ^a   Yang, Daofeng ^c   Ning, Qin ^c   Shen, Guanxin ^d   Li, Gang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chronic hepatitis B; IL 32; Inflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; INTERLEUKIN 23; MESSENGER RNA; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MALE; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; FEMALE; GENE EXPRESSION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

EID: 84865990848     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.05.009     Document Type: Article

References (31)

1. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000, 191:1269-1280.
2. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19:65-91.
3. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284:825-829.
4. Nold M.F., Nold-Petry C.A., Pott G.B., Zepp J.A., Saavedra M.T., Kim S.H., et al. Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 2008, 181:557-565.
5. Dinarello C.A., Kim S.H. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006, 65(Suppl. 3):i61-64.
6. Nishida A., Andoh A., Inatomi O., Fujiyama Y. Interleukin-32 expression in the pancreas. J Biol Chem 2009, 284:17868-17876.
7. Keswani A., Chustz R.T., Suh L., Carter R., Peters A.T., Tan B.K., et al. Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps. Allergy 2011.
8. Jeong H.J., Shin S.Y., Oh H.A., Kim M.H., Cho J.S., Kim H.M. IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Pathol 2011, 224:553-563.
9. Lee S., Kim J.H., Kim H., Kang J.W., Kim S.H., Yang Y., et al. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Immunology 2011, 132:410-420.
10. Moschen A.R., Fritz T., Clouston A.D., Rebhan I., Bauhofer O., Barrie H.D., et al. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology 2011, 53:1819-1829.
11. Pan X., Cao H., Lu J., Shu X., Xiong X., Hong X., et al. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-kappaB. Mol Immunol 2011, 48:1573-1577.
12. Xu X.W., Lu M.H., Tan D.M. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect 2005, 11:52-56.
13. Han M., Yan W., Guo W., Xi D., Zhou Y., Li W., et al. Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J Biol Chem 2008, 283:32715-32729.
14. Ke W.M., Xie S.B., Li X.J., Zhang S.Q., Lai J., Ye Y.N., et al. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume. J Viral Hepat 2011, 18:637-645.
15. Kobayashi H., Lin P.C. Molecular characterization of IL-32 in human endothelial cells. Cytokine 2009, 46:351-358.
16. Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis 2007, 27:152-160.
17. Felaco P., Castellani M.L., De Lutiis M.A., Felaco M., Pandolfi F., Salini V., et al. IL-32: a newly-discovered proinflammatory cytokine. J Biol Regul Homeost Agents 2009, 23:141-147.
18. Yang C.Y., Kuo T.H., Ting L.P. Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. J Biol Chem 2006, 281:34525-34536.
19. Zhou Y., Wang S., Ma J.W., Lei Z., Zhu H.F., Lei P., et al. Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes. J Biol Chem 2010, 285:12159-12168.
20. Shioya M., Nishida A., Yagi Y., Ogawa A., Tsujikawa T., Kim-Mitsuyama S., et al. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007, 149:480-486.
21. Chen Q., Carroll H.P., Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm 2006, 74:207-228.
22. Meyer N., Zimmermann M., Burgler S., Bassin C., Woehrl S., Moritz K., et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 2010, 125:858-865.
23. Goda C., Kanaji T., Kanaji S., Tanaka G., Arima K., Ohno S., et al. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 2006, 18:233-240.
24. Kim S.H., Han S.Y., Azam T., Yoon D.Y., Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22:131-142.
25. Netea M.G., Lewis E.C., Azam T., Joosten L.A., Jaekal J., Bae S.Y., et al. Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci U S A 2008, 105:3515-3520.
26. Xiang X., Gui H., King N.J., Cole L., Wang H., Xie Q., et al. IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunol Cell Biol 2011.
27. Cheon S., Lee J.H., Park S., Bang S.I., Lee W.J., Yoon D.Y., et al. Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells. J Biol Chem 2011, 286:12049-12055.
28. Dunn C., Brunetto M., Reynolds G., Christophides T., Kennedy P.T., Lampertico P., et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007, 204:667-680.
29. Jung M.Y., Son M.H., Kim S.H., Cho D., Kim T.S. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. J Immunol 2011, 186:6848-6859.
30. Zhang J.Y., Zhang Z., Lin F., Zou Z.S., Xu R.N., Jin L., et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010, 51:81-91.
31. Zhang Z., Chen D., Yao J., Zhang H., Jin L., Shi M., et al. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B. Clin Immunol 2007, 122:173-180.